Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.


Journal

Breast cancer (Tokyo, Japan)
ISSN: 1880-4233
Titre abrégé: Breast Cancer
Pays: Japan
ID NLM: 100888201

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 18 10 2019
accepted: 05 03 2020
pubmed: 18 3 2020
medline: 30 3 2021
entrez: 18 3 2020
Statut: ppublish

Résumé

Tumor-infiltrating lymphocytes are an important component of the tumor microenvironment (TME) in breast cancer. They have been linked with tumor pathogenesis in advanced stages. However, little is known about their contribution in early phases. In this study, we analyzed the infiltration of leukocytes and cancer stem cells (CSC) in tumors from patients with early breast cancer. Samples of blood and tumor tissue from 30 patients with breast cancer were collected, and the number of dendritic cells (DC), T cells, and CSC were analyzed by flow cytometry. Tumor-infiltrating CD4 and CD8 T cells expressed higher levels of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) compared with peripheral T cells. Regulatory T cells (Treg) were enriched in tumors and overexpressed glucocorticoid-induced TNFR-related protein and CTLA-4. Tumor Treg had a positive correlation with the amount of myeloid DC (mDC) and disease progression. The CD8/Treg ratio was associated with lymph node metastasis and tumor stages. The main subset of DC in early breast tumors was mDC, while plasmacytoid DC were almost absent. CSC were present in most tumors with higher frequencies in patients with lymph node metastasis. CSC were also associated with the amount of tumor-infiltrating Treg. Early breast cancer has an inflammatory milieu characterized by mDC, Treg, and CSC infiltration. The frequencies of Treg, CSC and CD8/Treg ratio were associated with disease progression. The composition of leukocytes and the presence of CSC in early breast tumors should be considered for the development of new therapeutic approaches.

Sections du résumé

BACKGROUND BACKGROUND
Tumor-infiltrating lymphocytes are an important component of the tumor microenvironment (TME) in breast cancer. They have been linked with tumor pathogenesis in advanced stages. However, little is known about their contribution in early phases. In this study, we analyzed the infiltration of leukocytes and cancer stem cells (CSC) in tumors from patients with early breast cancer.
METHODS METHODS
Samples of blood and tumor tissue from 30 patients with breast cancer were collected, and the number of dendritic cells (DC), T cells, and CSC were analyzed by flow cytometry.
RESULTS RESULTS
Tumor-infiltrating CD4 and CD8 T cells expressed higher levels of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) compared with peripheral T cells. Regulatory T cells (Treg) were enriched in tumors and overexpressed glucocorticoid-induced TNFR-related protein and CTLA-4. Tumor Treg had a positive correlation with the amount of myeloid DC (mDC) and disease progression. The CD8/Treg ratio was associated with lymph node metastasis and tumor stages. The main subset of DC in early breast tumors was mDC, while plasmacytoid DC were almost absent. CSC were present in most tumors with higher frequencies in patients with lymph node metastasis. CSC were also associated with the amount of tumor-infiltrating Treg.
CONCLUSION CONCLUSIONS
Early breast cancer has an inflammatory milieu characterized by mDC, Treg, and CSC infiltration. The frequencies of Treg, CSC and CD8/Treg ratio were associated with disease progression. The composition of leukocytes and the presence of CSC in early breast tumors should be considered for the development of new therapeutic approaches.

Identifiants

pubmed: 32180141
doi: 10.1007/s12282-020-01079-y
pii: 10.1007/s12282-020-01079-y
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

837-849

Subventions

Organisme : Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
ID : IA204515
Organisme : Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
ID : RA204515
Organisme : Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
ID : IA208717

Auteurs

Luis Alberto Solis-Castillo (LA)

Hospital de Gineco Obstetricia No. 3 del Centro Médico Nacional la Raza del Instituto Mexicano del Seguro Social, Ciudad de México, México.

Gina Stella Garcia-Romo (GS)

Unidad de morfología y función (UMF), Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Ave. De los Barrios No. 1., 54090, Tlalnepantla, Estado de México, México.
Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Estado de México, México.

Alvaro Diaz-Rodriguez (A)

Unidad de morfología y función (UMF), Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Ave. De los Barrios No. 1., 54090, Tlalnepantla, Estado de México, México.

Diana Reyes-Hernandez (D)

Unidad de morfología y función (UMF), Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Ave. De los Barrios No. 1., 54090, Tlalnepantla, Estado de México, México.

Elizabeth Tellez-Rivera (E)

Unidad de morfología y función (UMF), Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Ave. De los Barrios No. 1., 54090, Tlalnepantla, Estado de México, México.

Victor Hugo Rosales-Garcia (VH)

Laboratorios Nacionales de Servicios Experimentales (LANSE), Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Ciudad de México, México.

Adolfo Rene Mendez-Cruz (AR)

Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Estado de México, México.

Jose Rafael Jimenez-Flores (JR)

Unidad de morfología y función (UMF), Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Ave. De los Barrios No. 1., 54090, Tlalnepantla, Estado de México, México.
Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Estado de México, México.

Victor Hugo Villafana-Vazquez (VH)

Hospital de Gineco Obstetricia No. 3 del Centro Médico Nacional la Raza del Instituto Mexicano del Seguro Social, Ciudad de México, México.

Alexander Pedroza-Gonzalez (A)

Unidad de morfología y función (UMF), Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Ave. De los Barrios No. 1., 54090, Tlalnepantla, Estado de México, México. alexander_pg@yahoo.com.mx.
Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Estado de México, México. alexander_pg@yahoo.com.mx.
Unidad de investigación en Biomedicina (UBIMED), Facultad de Estudios Superiores Iztacala de la Universidad Nacional Autónoma de México, Estado de México, México. alexander_pg@yahoo.com.mx.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH